Skip to content
Polis

Senate bill · 89R

SB 1263

Relating to a pilot program for the safe disposal of prescription drugs, including controlled substance prescription drugs.

Did not pass

Progress

102 days from first to latest action, across 33 recorded actions.

  1. Filed

    Feb 13

  2. Referred to committee

    Feb 28

  3. Heard in committee

    Apr 23

  4. Reported from committee

    May 5

  5. Passed first chamber

    May 8

  6. Passed second chamber

    Stopped here

  7. Sent to governor

  8. Became law

HouseSenateMarAprMay

Filled marks are milestones (committee report, floor passage, governor action). Larger marks hold more same-day actions.

Record votes

Each dot is one member, grouped by how they voted.

passage

Senate · May 8, 2025

Passed 28–3

28 Yea

3 Nay

0 Absent / not voting

RepublicanDemocratic

Senate Rule 7.18 and the Constitutional Rule requiring bills to be read on three several days be suspended and that CSSB 1263 be placed on its third reading and final passage.

Senate · May 8, 2025

Passed 28–3

28 Yea

3 Nay

0 Absent / not voting

RepublicanDemocratic

Full history

Every action recorded by Texas Legislature Online.

  1. Placed on General State Calendar

    May 26, 2025 · House

  2. Considered in Calendars

    May 24, 2025 · House

  3. Committee report sent to Calendars

    May 23, 2025 · House

  4. Committee report distributed

    May 22, 2025 · House

  5. Comte report filed with Committee Coordinator

    May 22, 2025 · House

  6. Reported favorably w/o amendment(s) Public Health

    May 19, 2025 · House

  7. Considered in public hearing Public Health

    May 19, 2025 · House

  8. Referred to Public Health Public Health

    May 10, 2025 · House

  9. Read first time

    May 10, 2025 · House

  10. Received from the Senate

    May 8, 2025 · House

  11. Reported engrossed

    May 8, 2025 · Senate

  12. Record vote

    May 8, 2025 · Senate

  13. Passed

    May 8, 2025 · Senate

  14. Read 3rd time

    May 8, 2025 · Senate

  15. Record vote

    May 8, 2025 · Senate

  16. Three day rule suspended

    May 8, 2025 · Senate

  17. Record vote

    May 8, 2025 · Senate

  18. Read 2nd time & passed to engrossment

    May 8, 2025 · Senate

  19. Record vote

    May 8, 2025 · Senate

  20. Rules suspended-Regular order of business

    May 8, 2025 · Senate

  21. Co-author authorized

    May 8, 2025 · Senate

  22. Placed on intent calendar

    May 7, 2025 · Senate

  23. Committee report printed and distributed

    May 5, 2025 · Senate

  24. Reported favorably as substituted Health and Human Services

    May 5, 2025 · Senate

  25. Vote taken in committee

    Apr 30, 2025 · Senate

  26. Considered in public hearing Health and Human Services

    Apr 30, 2025 · Senate

  27. Left pending in committee

    Apr 23, 2025 · Senate

  28. Considered in public hearing Health and Human Services

    Apr 23, 2025 · Senate

  29. Scheduled for public hearing on . . .

    Apr 23, 2025 · Senate

  30. Referred to Health & Human Services Health and Human Services

    Feb 28, 2025 · Senate

  31. Read first time

    Feb 28, 2025 · Senate

  32. Filed

    Feb 13, 2025 · Senate

  33. Received by the Secretary of the Senate

    Feb 13, 2025 · Senate

Authors

and 2 coauthors or sponsors

Show 2 more
  • José Menéndez cosponsorD
  • Sarah Eckhardt cosponsorD

In committee

Topics

Bill text

Bills on similar topics

Other legislation this session sharing the most index topics.

BillAuthorProgressStatusLast action
HB 1837Relating to the enforcement and prevention of offenses involving the manufacture or delivery of controlled substances listed in Penalty Group 1 or 1-B, law enforcement officer safety in handling those substances, and the manufacture and proper use of opioid antagonists.Ryan GuillenRPassed first chamberDid not passMay 13, 2025Referred to Criminal Justice
HB 3717Relating to the establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy.Cody HarrisRReported from committeeDid not passMay 12, 2025Laid on the table subject to call
HB 5248Relating to a pilot program for the safe disposal of prescription drugs, including controlled substance prescription drugs.Ryan GuillenRReported from committeeDid not passMay 15, 2025Placed on General State Calendar
SB 541Relating to cottage food production operations.Lois KolkhorstRBecame lawBecame lawMay 30, 2025Effective on 9/1/25
SB 2308Relating to the establishment of a consortium to conduct United States Food and Drug Administration's drug development clinical trials with ibogaine to secure the administration's approval of the medication's use for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy and to the administration of that treatment.Tan ParkerRBecame lawBecame lawJun 11, 2025Effective immediately
HB 130Relating to genetic information security for residents of this state; providing a civil penalty; providing a private cause of action.Greg BonnenRBecame lawBecame lawJun 20, 2025Effective on 9/1/25
SB 1263 (89R) · Polis